These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 4582081)
1. A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man. Perez-Reyes M; Timmons MC; Lipton MA; Christensen HD; Davis KH; Wall ME Experientia; 1973 Aug; 29(8):1009-10. PubMed ID: 4582081 [No Abstract] [Full Text] [Related]
2. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol. Perez-Reyes M; Timmons MC; Davis KH; Wall EM Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242 [No Abstract] [Full Text] [Related]
3. 11-hydroxy- 9 -tetrahydrocannabinol: pharmacology, disposition, and metabolism of a major metabolite of marihuana in man. Lemberger L; Crabtree RE; Rowe HM Science; 1972 Jul; 177(4043):62-4. PubMed ID: 5041775 [TBL] [Abstract][Full Text] [Related]
4. Pharmacologic effects and physiologic disposition of delta 6a,10a dimethyl heptyl tetrahydrocannabinol (DMHP) in man. Lemberger L; McMahon R; Archer R; Matsumoto K; Rowe H Clin Pharmacol Ther; 1974 Apr; 15(4):380-6. PubMed ID: 4821441 [No Abstract] [Full Text] [Related]
5. Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration. Hollister LE; Gillespie HK Clin Pharmacol Ther; 1973; 14(3):353-7. PubMed ID: 4698563 [No Abstract] [Full Text] [Related]
6. Intravenous injection in man of 9 -tetrahydrocannabinol and 11-OH- 9 -tetrahydrocannabinol. Perez-Reyes M; Timmons MC; Lipton MA; Davis KH; Wall ME Science; 1972 Aug; 177(4049):633-5. PubMed ID: 4558903 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of delta9-tetrahydrocannabinol. Hollister LE Pharmacology; 1974; 11(1):3-11. PubMed ID: 4610598 [No Abstract] [Full Text] [Related]
8. Effect of delta-9-tetrahydrocannabinol on intraocular pressure in humans. Cooler P; Gregg JM South Med J; 1977 Aug; 70(8):951-4. PubMed ID: 329423 [TBL] [Abstract][Full Text] [Related]
9. Letter: Marihuana dosage control through heart rate. Schaefer CF; Gunn CG; Dubowski KM N Engl J Med; 1975 Jul; 293(2):101. PubMed ID: 1128639 [No Abstract] [Full Text] [Related]
12. Lack of tolerance to the bradycardic effect of delta 9-trans-tetrahydrocannabinol in rats. Kaymakçalan S; Sivil S Pharmacology; 1974; 12(4-5):290-5. PubMed ID: 4449891 [No Abstract] [Full Text] [Related]
13. Effects of delta-9-tetrahydrocannabinol on halothane MAC in dogs. Stoelting RK; Martz RC; Gartner J; Creasser C; Brown DJ; Forney RB Anesthesiology; 1973 Jun; 38(6):521-4. PubMed ID: 4706747 [No Abstract] [Full Text] [Related]
16. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man. Freemon FR; Rosenblatt JE; EL-Yousef MK Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392 [TBL] [Abstract][Full Text] [Related]
17. Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man. Karniol IG; Shirakawa I; Kasinski N; Pfeferman A; Carlini EA Eur J Pharmacol; 1974 Sep; 28(1):172-7. PubMed ID: 4609777 [No Abstract] [Full Text] [Related]
18. Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice. Gill EW; Jones G; Lawrence DK Biochem Pharmacol; 1973 Jan; 22(2):175-84. PubMed ID: 4763251 [No Abstract] [Full Text] [Related]
19. Comparative studies in man and in laboratory animals on 8 - and 9 -trans-tetrahydrocannabinol. Karniol IG; Carlini EA Pharmacology; 1973; 9(2):115-26. PubMed ID: 4713005 [No Abstract] [Full Text] [Related]